Urinary transforming growth factor-β1 in various types of nephropathy

Pharmacological Research

Volumn 49, Issue 3, 2004, Pages 293-298

  De Muro, Pierina ^a   Faedda, Rossana ^a   Fresu, Pietro ^a   Masala, Antonio ^a   Cigni, Alessandro ^a   Concas, Gordiano ^a   Mela, Maria Graziella ^a   Satta, Andrea ^a   Carcassi, Aldo ^a   Sanna, Giovanni Maria ^b   Cherchi, Gian Mario ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b Operative Unit   (Italy)

Author keywords

Glomerulonephritis; HbA1C; Mesangial proliferation; TGF 1; Type 1 (insulin dependent) diabetes mellitus

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; HEMOGLOBIN A1C; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DISEASE ACTIVITY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOCCULATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIAL GLOMERULONEPHRITIS; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY EXCRETION;

EID: 0346690094     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.10.003     Document Type: Article

References (34)

1. Border W.A., Noble N.A. TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int. 51:1997;1388-1396.
2. Sharma K., Ziyadeh F.N. The emerging role of transforming growth factor-β in kidney diseases. Am. J. Physiol. 266:1994;F829-F842.
3. Yamamoto T., Noble N.A., Miller D.E., Border W.A. Sustained expression of TGF-β 1 underlies development of progressive kidney fibrosis. Kidney Int. 45:1994;916-927.
4. Yamamoto T., Nakamura T., Noble N.A., Ruoslahti E., Border W.A. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1814-1818.
5. Tamaki K., Okuda S., Ando T., Iwamoto T., Nakayama M., Fujishima M. TGF-β 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int. 45:1994;525-536.
6. Yamamoto T., Noble N.A., Cohen A.H., Nast C.C., Hishida A., Gold L.I.et al. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int. 49:1996, February;461-469.
7. Border W.A., Okuda S., Languino L.R., Sporn M.B., Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β 1. Nature. 346:1990;371-374.
8. Isaka Y., Brees D.K., Ikegaya K., Kaneda Y., Imai E., Noble N.A.et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. Med. 2:1996;418-423.
9. Kopp J.B., Factor V.M., Mozes M., Nagy P., Sanderson N., Bottinger E.P. et al. Transgenic mice with increased plasma levels of TGF-β 1 develop progressive renal disease. Lab. Invest. 74:1996;991-1003.
10. Kitamura M., Burton S., English J., Kawachi H., Fine L.G. Transfer of a mutated gene encoding active transforming growth factor-β 1 suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int. 48:1995;1747-1757.
11. Sharma K., Ziyadeh F.N., Alzahabi B., McGowan T.A., Kapoor S., Kurnik B.R.et al. Increased renal production of transforming growth factor-β1 in patients with type II diabetes. Diabetes. 46:1997, May;854-859.
12. Murakami K., Takemura T., Hino S., Yoshioka K. Urinary transforming growth factor-β in patients with glomerular diseases. Pediatr. Nephrol. 11:1997;334-336.
13. Kanai H., Mitsuhashi H., Ono K., Yano S., Naruse T. Increased excretion of urinary transforming growth factor β in patients with focal glomerular sclerosis. Nephron. 66:1994;391-395.
14. Coupes B.M., Newstead C.G., Short C.D., Brenchley P.E. Transforming growth factor β 1 in renal allograft recipients. Transplantation. 57:1994;1727-1731.
15. Sato H., Iwano M., Akai Y., Kurioka H., Kubo A., Yamaguchi T.et al. Increased excretion of urinary transforming growth factor β 1 in patients with diabetic nephropathy. Am. J. Nephrol. 18:1998;490-494.
16. Korpinen E., Teppo A.M., Hukkanen L., Akerblom H.K., Gronhagen-Riska C., Vaarala O. Urinary transforming growth factor-β1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care. 23:2000;664-668.
17. Lyons R.M., Moses H.L. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187:1990;467-473.
18. Okuda S., Languino L.R., Ruoslahti E., Border W.A. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J. Clin. Invest. 86:1990;453-462.
19. Kitamura M., Suto T., Yokoo T., Shimizu F., Fine L.G. Transforming growth factor-β 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J. Immunol. 156:1996;2964-2971.
20. Suto T.S., Fine L.G., Kitamura M. Mesangial cell-derived transforming growth factor-β 1 reduces macrophage adhesiveness with consequent deactivation. Kidney Int. 50:1996;445-452.
21. Lacave R., Rondeau E., Ochi S., Delarue F., Schleuning W.D., Sraer J.D. Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int. 35:1989;806-811.
22. Lyons R.M., Keski-Oja J., Moses H.L. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J. Cell Biol. 106:1988;1659-1665.
23. Border W.A., Noble N.A. Cytokines in kidney disease: the role of transforming growth factor-β Am. J. Kidney Dis. 22:1993;105-113.
24. Wolf G., Zahner G., Schroeder R., Stahl R.A. Transforming growth factor β mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol. Dial. Transplant. 11:1996;263-269.
25. Kagami S., Border W.A., Miller D.E., Noble N.A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93:1994;2431-2437.
26. Wolf G., Ziyadeh F.N. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 56:1999;393-405.
27. Border W.A., Noble N.A. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension. 31:1998;181-188.
28. Sharma K., Eltayeb B.O., McGowan T.A., Dunn S.R., Alzahabi B., Rohde R. et al. Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am. J. Kidney Dis. 34:1999;818-823.
29. Murakami K., Takemura T., Hino S., Yoshioka K. Urinary transforming growth factor-β in patients with glomerular diseases. Pediatr. Nephrol. 11:1997;334-336.
30. Honkanen E., Teppo A.M., Tornroth T., Groop P.H., Gronhagen-Riska C. Urinary transforming growth factor-β 1 in membranous glomerulonephritis. Nephrol. Dial. Transplant. 12:1997;2562-2568.
31. Haramaki R., Tamaki K., Fujisawa M., Ikedo H., Haramaki N., Okuda S. Steroid therapy and urinary transforming growth factor-β1 in IgA nephropathy. Am. J. Kidney Dis. 38:2001;1191-1198.
32. Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-De La Cruz M.C., Hong S.W., Isono M.et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8015-8020.
33. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
34. Ziyadeh F.N., Sharma K., Ericksen M., Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β J. Clin. Invest. 93:1994;536-542.